AXSM

Axsome Therapeutics $220.75 1M +2.8% 3M -13.0% YTD +23.5% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
+0.6%
Next 1 month
-0.2%
Seasonality
Mildly negative window
Next 30 days (to Oct 14): -3.3% median, 50% of the last 10 years finished up.
20-year seasonality chart →
Mean reversion
Deeply overbought — RSI(2) at 98
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.03%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.59 -0.1% · Seasonal tilt (10y) -0.1%
$116M/day volume 43% volatility +78% 1-year -15% from ATH
52-week range · 73% of the way up · -15% from the high
$112.90$260.19

Congressional trades in AXSM Full tracker →

1 member · 1 buys / 0 sells · $15K–$50K disclosed · latest filing Jul 28, 2022.

BUY CJ Christopher L. Jacobs · traded Jun 16, 2022 $15K–$50K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.